A recent study revealed that intermittent fasting may assist patients accomplish long-term remission from Crohn’s disease.

News and commentary from the world of gastroenterology and hepatology ...

"Our results indicate that [the presence of micro- and nanoplastics] is a previously underestimated factor in the development ...

Inflammatory bowel disease (IBD) is typically diagnosed after the onset of symptoms in the context of established, ...

Thetis Pharmaceuticals, LLC ("Thetis"), a clinical-stage company developing TP-317, a first-in-class, oral BLT1 agonist for inflammatory bowel disease (IBD) and cancer, today announced the appointment ...

GLP-1 receptor agonists offer more than weight loss for patients with inflammatory bowel disease, with markedly improved ...

Inflammatory bowel disease (IBD) is an umbrella term for a group of chronic conditions that cause inflammation and swelling ...

Time-restricted feeding (TRF), a form of intermittent fasting, led to meaningful reductions in clinical disease activity and ...

More than 100,000 young Americans under the age of 20 live with inflammatory bowel disease, a pioneering study has revealed. The study, funded by the Centers for Disease Control and Prevention, ...

For the first time, a major trigger in inflammatory bowel disease (IBD) and related conditions has been identified, and existing drugs are capable of blocking it. It's a "massive step" in successfully ...